These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33853160)

  • 21. Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer.
    Chuang CM; Monie A; Wu A; Mao CP; Hung CF
    Hum Gene Ther; 2009 Apr; 20(4):303-13. PubMed ID: 19272013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
    Moseman EA; Liang X; Dawson AJ; Panoskaltsis-Mortari A; Krieg AM; Liu YJ; Blazar BR; Chen W
    J Immunol; 2004 Oct; 173(7):4433-42. PubMed ID: 15383574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.
    Zhang M; Yin T; Lu Y; Feng H
    Med Sci Monit; 2016 Apr; 22():1309-17. PubMed ID: 27092689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of adipose-derived stem cells and non-methylated CpG-oligodeoxynucleotides on peripheral blood CD4
    Chen XL; Zheng CZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):590-595. PubMed ID: 28506355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
    Adamsson J; Lindblad M; Lundqvist A; Kelly D; Holmgren J; Harandi AM
    J Immunol; 2006 Apr; 176(8):4902-13. PubMed ID: 16585586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.
    Liu HM; Newbrough SE; Bhatia SK; Dahle CE; Krieg AM; Weiner GJ
    Blood; 1998 Nov; 92(10):3730-6. PubMed ID: 9808567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung.
    Yamada H; Ishii KJ; Klinman DM
    Crit Care Med; 2004 Oct; 32(10):2045-9. PubMed ID: 15483413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study.
    Otsuka T; Nishida S; Shibahara T; Temizoz B; Hamaguchi M; Shiroyama T; Kimura K; Miyake K; Hirata H; Mizuno Y; Yagita M; Manabe Y; Kuroda E; Takeda Y; Kida H; Ishii KJ; Kumanogoh A
    BMC Cancer; 2022 Jul; 22(1):744. PubMed ID: 35799134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage.
    Slotta JE; Scheuer C; Menger MD; Vollmar B
    J Hepatol; 2006 Mar; 44(3):576-85. PubMed ID: 16310279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses.
    Maurer T; Pournaras C; Aguilar-Pimentel JA; Thalgott M; Horn T; Heck M; Heit A; Kuebler H; Gschwend JE; Nawroth R
    Urol Oncol; 2013 Oct; 31(7):1395-401. PubMed ID: 21982682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.
    Heckelsmiller K; Rall K; Beck S; Schlamp A; Seiderer J; Jahrsdörfer B; Krug A; Rothenfusser S; Endres S; Hartmann G
    J Immunol; 2002 Oct; 169(7):3892-9. PubMed ID: 12244187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
    Becker Y
    Virus Genes; 2005 Mar; 30(2):251-66. PubMed ID: 15744581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
    Luo Y; Fu X; Ru R; Han B; Zhang F; Yuan L; Men H; Zhang S; Tian S; Dong B; Meng M
    Arch Med Res; 2020 Apr; 51(3):233-244. PubMed ID: 32139108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1141-9. PubMed ID: 16911828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.
    Kajiwara A; Doi H; Eguchi J; Ishii S; Hiraide-Sasagawa A; Sakaki M; Omori R; Hiroishi K; Imawari M
    Oncol Rep; 2012 Jun; 27(6):1765-71. PubMed ID: 22426807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.